Quell Revenue and Competitors
Estimated Revenue & Valuation
- Quell's estimated annual revenue is currently $4.3M per year.
- Quell's estimated revenue per employee is $112,000
Employee Data
- Quell has 38 Employees.
- Quell grew their employee count by -33% last year.
Quell's People
Name | Title | Email/Phone |
---|
Quell Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $216.6M | 1105 | 37% | N/A | N/A |
#2 | $2.4M | 24 | -52% | N/A | N/A |
#3 | $17.5M | 125 | -6% | N/A | N/A |
#4 | $19.3M | 138 | -4% | $68M | N/A |
#5 | $25.4M | 165 | 11% | N/A | N/A |
#6 | $82.8M | 473 | -1% | N/A | N/A |
#7 | $3.9M | 35 | -10% | N/A | N/A |
#8 | $4.4M | 39 | -5% | N/A | N/A |
#9 | $8.1M | 64 | -16% | N/A | N/A |
#10 | $0.5M | 15 | -17% | $23M | N/A |
What Is Quell?
An immersive fitness adventure bringing your workout anywhere. Join today.
keywords:N/AN/A
Total Funding
38
Number of Employees
$4.3M
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Quell News
2022-04-20 - If the US Wants to Help Quell the Violence in Israel, It Should ...
If the U.S. Wants to Help Quell the Violence in Israel, It Should Apply Pressure on Qatar and the Palestinian Authority. April 29 2022.
2022-04-20 - Strategic Collaboration Set to Develop iPSC-derived Cell ...
Quell Therapeutics and Cellistic aim to develop next-gen platform for creation of off-the-shelf Treg cell therapies targeting a wide range...
2022-04-20 - If the US Wants to Help Quell the Violence in Israel, It Should ...
If the U.S. Wants to Help Quell the Violence in Israel, It Should Apply Pressure on Qatar and the Palestinian Authority. April 29 2022.
2022-04-20 - Strategic Collaboration Set to Develop iPSC-derived Cell ...
Quell Therapeutics and Cellistic aim to develop next-gen platform for creation of off-the-shelf Treg cell therapies targeting a wide range...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.6M | 38 | 27% | N/A |
#2 | $7.1M | 38 | -54% | N/A |
#3 | $6.2M | 38 | -38% | N/A |
#4 | $6.2M | 38 | 31% | N/A |
#5 | $4.4M | 38 | 9% | N/A |